newest glp 1 medication The Rise of GLP-1 Medications – Magnet GLP-1 Drug Pipeline 2026 |

For instance, research on Semaglutide 2.4 mg shows it can reduce calorie intake by about 35%

For pharmacies, this shift is immediately visible

Other lipid-lowering therapies include: Ezetimibe : Reduces LDL cholesterol by approximately 1520% by inhibiting intestinal cholesterol absorption Bempedoic acid : Lowers LDL cholesterol by 15-25%, often used with ezetimibe when statins are contraindicated or not tolerated PCSK9 inhibitors : Achieve dramatic LDL reductions of 5060%, reserved for patients with very high cardiovascular risk or familial hypercholesterolaemia Fibrates : Primarily target triglycerides (reductions of 3050%) with modest effects on LDL cholesterol Icosapent ethyl : A prescription-grade omega-3 fatty acid that may be used in selected high-risk patients

These medicines can help with weight management when you use them with a healthy diet and some activity